Company / SG&A per Share
Haemonetics SG&A per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.91
FY2026
5-year range
$7.33 / $8.91
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#48 of 156
Health Care
What the data says
At $8.91, Haemonetics's sg&a per share ranks #109 of 156 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $5.37 in FY2020 to $8.91 in FY2026.
Based on SEC 10-K filings.
8.91 in FY2026 with a 5-year CAGR of +6.1%.
Increased from $8.40 to $8.91 over the past 3 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.0%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
#109 of 156 in Health CareTop 69% of 156This company $8.91 Sector average $11421.53
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #48 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $8.91 | - |
| FY2025 | - | - |
| FY2024 | $8.66 | +3.1% |
| FY2023 | $8.40 | +14.7% |
| FY2022 | $7.33 | +10.6% |
| FY2021 | $6.62 | +23.4% |
| FY2020 | $5.37 | -1.4% |
| FY2019 | $5.44 | +4.0% |
| FY2018 | $5.23 | -15.8% |
| FY2017 | $6.21 | +6.4% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026